Every story stays here. Filter by topic, search older headlines, and save favorites to your member record. Educational notes only — not medical advice.
Study (pilot RCT). Martinez, Fitzgerald, Weber and colleagues randomised community-dwelling adults aged 60–90 to 24 weeks of traditional Hatha yoga or high-speed cued YogaCue (visual, verbal, and auditory sequence switches), three 60-minute sessions a week. Of 54 randomised, 34 completed testing. Both groups improved some cognitive and physical scores; YogaCue showed extra gains on some memory, aerobic, and physical-performance measures, while Hatha drove more strength and timed-up-and-go change. Small, predominantly female sample with no non-exercise control. Educational training notes, not a diagnosis.
Study (observational cohort). Zacher, Vogel and Leipzig colleagues report in the European Journal of Clinical Nutrition (doi 10.1038/s41430-026-01817-z) on 1,404 pregnant women in Germany’s LIFE Child cohort (2011–2025; 1,196 newborns). Hierarchical clustering found four patterns: mixed, traditional bread-based, high ultra-processed, and vegetable-rich. The high-UPF cluster was younger, with lower socioeconomic status, higher pre-pregnancy BMI, and higher gestational weight gain; the vegetable-rich cluster was older, with lower BMI. Infant birth-weight and SGA/LGA differences were mostly non-significant; vegetable-rich infants had slightly higher gestational-age-adjusted length. Single diet recall; German cohort. Educational nutrition notes, not a pregnancy diet prescription.
Commentary covering a study. Yale researchers (Sehgal, Higgins-Chen and colleagues) pooled 51 human intervention studies in Nature Medicine and ran the same panel of 16 epigenetic clocks plus 94 other DNA-methylation markers. Diet patterns (Mediterranean, low-carb, or low-fat) plus regular exercise consistently lowered clock estimates. Prescription metformin, semaglutide, and anti-TNF therapies showed the largest average clock drops, often in people already treated for disease. Over-the-counter supplements were limited and inconsistent. Authors stress that a biomarker shift is not proof of extra healthy years. Metformin and GLP-1 drugs remain prescription medicines; off-label longevity use is clinician-only. This is not medical advice. Educational supplement parallel (not a replacement): When longevity headlines discuss metformin, people often also research berberine. That is an off-label / curiosity parallel, not a recommendation to take berberine instead of metformin. Human longevity outcome data for both are limited; disease-use of metformin is clinician-prescribed. Weakly evidenced as an anti-aging product. Store: /store/berberine. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.
Study (cultured mouse muscle cells). Shinshu University researchers report in Food Bioscience (1 Sept 2026) that pterostilbene, a polyphenol in blueberries and grapes, cut lipid droplets in C2C12 myocytes by stabilizing PPARδ rather than blocking fat uptake. Cells still differentiated normally and showed more fat-oxidation gene activity. This is a dish experiment, not a human trial and not a reason to treat insulin resistance or myosteatosis with a berry extract. Food-first berries are fine; concentrated supplements are weakly evidenced for this claim.
Study. Concordia University researchers (Emmanuel Frimpong, Arsenio Paez, Thien Thanh Dang-Vu and colleagues) report in SLEEP that 88 healthy young adults were randomized to 8.5 versus 4.5 hours in bed, with or without 30 minutes of moderate evening cycling (about 55–60% of VO2 max). After a 4.5-hour night, people who had cycled scored as well on delayed face–name recall as those who slept 8.5 hours. Slow-wave sleep statistically mediated the exercise–memory link. Immediate recall was similar across groups. This is an acute lab session in young volunteers, not a dementia trial and not a license to skip sleep. Educational movement notes.
Study (mice; ScienceDaily coverage dated 4 Sept 2026 of a 2022 Frontiers paper). Xi'an Jiaotong-Liverpool, Stanford and collaborators reported that plasmalogen lipids abundant in edible sea squirts improved Morris-water-maze learning in aged mice, with more synapses, less brain inflammation, and thicker darker fur. The underlying paper is in Frontiers in Molecular Biosciences (2022). This is laboratory animal work, not evidence that eating sea squirts or taking plasmalogen pills reverses human aging. Human trials would be required; supplements marketed on this headline are weakly evidenced.
Study (mice). Salk Institute researchers led by Gerald Shadel report in Science Advances that brief mitochondrial stress during mouse embryonic development later protected adult hearts from doxorubicin, a chemotherapy drug that can damage mitochondria. Superoxide buildup led mitochondria to release citrate, which converted to acetyl-CoA and left lasting epigenetic “mitohormesis” marks. This is laboratory animal work, not a human longevity trial and not a reason to take antioxidant pills or skip prescribed heart or cancer care. Mitohormesis as an anti-aging product is weakly evidenced.
Commentary. A Medical Xpress science roundup (Sept. 4, 2026) argues that ice baths, compression, massage, and recovery supplements often trim soreness a little without restoring muscle function much. Stronger evidence sits with basics: 7–9 hours of sleep, 20–40 g protein after training plus carbohydrate to refill glycogen, and a plan with rest days. Omega-3 pills are unlikely to vastly improve recovery versus food. This is educational training hygiene, not a supplement protocol and not a diagnosis.
Study (multicentre RCT). STAMINA investigators report in The Lancet Oncology (4 September 2026) that 389 men on androgen-deprivation therapy for prostate cancer were randomized to 12 months of supervised aerobic plus resistance exercise, dietary advice, behavioural support and gym membership versus enhanced usual care (n=311). STAMINA improved FACT-P by 4.5 points (p=0.0004) and FACIT-F fatigue by 1.9 (p=0.0068) at 12 months. Open-label NHS setting. Educational exercise notes, not a cancer treatment.
Commentary. A Nature Aging research highlight on mouse work in which GLP-1 receptor agonism was associated with a longer median lifespan. This is laboratory animal research, not a human trial and not a reason to start, stop, or change any medicine. VitaLonga does not prescribe GLP-1 drugs or sell them as longevity treatments. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.
Commentary. Meeting report from the SENESCENCE2030 conference in Coimbra (May 2026). Researchers sketched priorities: classifying senescent cell states, standardizing biomarkers, and coordinating translation. Educational context for how the field talks about cellular aging — not a clinic visit and not a supplement protocol.
Study (mice and human cells). Stanford Medicine researchers report in Science that tissue-resident macrophages lose the ability to clear senescent neutrophils with age. Blocking the PGE2 receptor EP2 on those macrophages in mice restored cleanup and left older animals leaner, stronger, and sharper across brain, heart, muscle, liver, and other organs. Human liver-cell data showed similar neutrophil buildup and EP2 activity with age. This is laboratory and observational tissue work, not a clinic protocol. No approved EP2-selective drug exists; NSAIDs that broadly lower prostaglandins are not a longevity prescription.
VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.
